Inherited cancer predisposing mutations in patients with therapy‐related myeloid neoplasms-Reference-Cited by-同舟云学术

Inherited cancer predisposing mutations in patients with therapy‐related myeloid neoplasms

Published:2022-11-09 Issue:4 Volume:200 Page:489-493
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Shih Andrew J.¹,Jun Tomi²^ORCID,Skol Andrew D.³,Bao Riyue⁴⁵,Huang Lei⁶,Vora Sapana³,McNerney Megan E.³⁷^ORCID,Hungate Eric A.³,Le Beau Michelle M.⁸,Larson Richard A.⁸,Elliott Aaron⁹,Lu Hsiao‐Mei⁹,Huether Robert⁹,Hernandez Felicia⁹,Stölzel Friedrich¹⁰,Allan James M.¹¹,Onel Kenan²¹²

Affiliation:

1. The Feinstein Institute for Medical Research, Northwell Health Manhasset New York USA

2. Sema4 Stamford Connecticut USA

3. Department of Pediatrics The University of Chicago Chicago Illinois USA

4. Department of Medicine The University of Pittsburgh Pittsburgh Pennsylvania USA

5. UPMC Hillman Cancer Center Pittsburgh Pennsylvania USA

6. Center for Research Informatics, The University of Chicago Chicago Illinois USA

7. Department of Pathology The University of Chicago Chicago Illinois USA

8. Department of Medicine The University of Chicago Chicago Illinois USA

9. Ambry Genetics Aliso Viejo California USA

10. Department of Internal Medicine I University Hospital Carl Gustav Carus Dresden, Dresden University of Technology Dresden Germany

11. Northern Institute for Cancer Research, Newcastle University Newcastle upon Tyne UK

12. Department of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai New York New York USA

Funder

American Cancer Society

Cancer Research Foundation

National Institutes of Health

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.18543

Reference15 articles.

1. Incidence and susceptibility to therapy-related myeloid neoplasms

2. Identification of a Novel TP53 Cancer Susceptibility Mutation Through Whole-Genome Sequencing of a Patient With Therapy-Related AML

3. Inherited mutations in cancer susceptibility genes are common among survivors of breast cancer who develop therapy-related leukemia

4. Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer

5. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION;Mediterranean Journal of Hematology and Infectious Diseases;2023-10-30

2. How I diagnose myeloid neoplasms with germline predisposition;American Journal of Clinical Pathology;2023-07-18